©The Author(s) 2022.
World J Clin Pediatr. Mar 9, 2022; 11(2): 136-150
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.136
Published online Mar 9, 2022. doi: 10.5409/wjcp.v11.i2.136
Table 2 Clinical and laboratory red flags
| Clinical red flags |
| Early onset in childhood: The development of complex inflammatory disorders before puberty and particularly before early childhood rises suspicion of a congenital immune dysregulation |
| Overlap of symptoms in distinct specialties: A clinical history of distinct rheumatologic and non-rheumatologic conditions is not common in pediatrics, addressing a monogenic disorder |
| Lymphoproliferative manifestations: The presence of splenomegaly and/or lymphadenopathy in association with inflammatory or autoimmune diseases suggests an underlying inborn error of immunity. |
| Recurrent infections: The recurrence of severe or atypical infections (especially candidiasis) in association with inflammatory or autoimmune diseases is rarely a consequence of immunomodulatory therapies in children, but it does suggest an immunological defect |
| Familiarity with autoimmunity: The clustering of autoimmune disorders in families acknowledges a likely monogenic cause |
| Laboratory red flags |
| Hypogammaglobulinemia |
| Hypergammaglobulinemia |
| Leukopenia |
| Hypereosinophilia |
| Wide positivity of autoantibodies |
| Positive interferon signature |
- Citation: Boz V, Zanchi C, Levantino L, Riccio G, Tommasini A. Druggable monogenic immune defects hidden in diverse medical specialties: Focus on overlap syndromes. World J Clin Pediatr 2022; 11(2): 136-150
- URL: https://www.wjgnet.com/2219-2808/full/v11/i2/136.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v11.i2.136